Cargando…
Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer
We developed a decision aid (DA) for patients with metastatic non-small cell lung cancer (NSCLC), to better inform patients of their prognosis and treatment options, and facilitate involvement in decision-making. In a pilot study, 20 patients with metastatic NSCLC attending outpatient clinics at a m...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410111/ https://www.ncbi.nlm.nih.gov/pubmed/18506180 http://dx.doi.org/10.1038/sj.bjc.6604395 |
_version_ | 1782155927877582848 |
---|---|
author | Leighl, N B Shepherd, F A Zawisza, D Burkes, R L Feld, R Waldron, J Sun, A Payne, D Bezjak, A Tattersall, M H N |
author_facet | Leighl, N B Shepherd, F A Zawisza, D Burkes, R L Feld, R Waldron, J Sun, A Payne, D Bezjak, A Tattersall, M H N |
author_sort | Leighl, N B |
collection | PubMed |
description | We developed a decision aid (DA) for patients with metastatic non-small cell lung cancer (NSCLC), to better inform patients of their prognosis and treatment options, and facilitate involvement in decision-making. In a pilot study, 20 patients with metastatic NSCLC attending outpatient clinics at a major cancer centre, who had already made a treatment decision, reviewed acceptability of the DA. The median age of the patients was 61 years (range 37–77 years), 35% were male, 20% had a university education, and most (75%) had English as a first language. Most had received chemotherapy, with 65% currently on treatment. Patients were not anxious at baseline and had clear understanding of the goals and toxicity of chemotherapy in advanced NSCLC. After reviewing the DA, patients' anxiety decreased slightly (P=0.04) and knowledge scores improved by 25% (P<0.001). Most improvements in understanding were of prognosis with and without chemotherapy, although patients still believed advanced NSCLC to be curable. Patients rated the DA highly with respect to information clarity, usefulness and were positive about its use in practice, although 40% found the prognostic information slightly upsetting. The DA for advanced NSCLC is feasible, acceptable to patients and improves understanding of advanced NSCLC without increasing patient anxiety. |
format | Text |
id | pubmed-2410111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-24101112009-09-10 Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer Leighl, N B Shepherd, F A Zawisza, D Burkes, R L Feld, R Waldron, J Sun, A Payne, D Bezjak, A Tattersall, M H N Br J Cancer Clinical Study We developed a decision aid (DA) for patients with metastatic non-small cell lung cancer (NSCLC), to better inform patients of their prognosis and treatment options, and facilitate involvement in decision-making. In a pilot study, 20 patients with metastatic NSCLC attending outpatient clinics at a major cancer centre, who had already made a treatment decision, reviewed acceptability of the DA. The median age of the patients was 61 years (range 37–77 years), 35% were male, 20% had a university education, and most (75%) had English as a first language. Most had received chemotherapy, with 65% currently on treatment. Patients were not anxious at baseline and had clear understanding of the goals and toxicity of chemotherapy in advanced NSCLC. After reviewing the DA, patients' anxiety decreased slightly (P=0.04) and knowledge scores improved by 25% (P<0.001). Most improvements in understanding were of prognosis with and without chemotherapy, although patients still believed advanced NSCLC to be curable. Patients rated the DA highly with respect to information clarity, usefulness and were positive about its use in practice, although 40% found the prognostic information slightly upsetting. The DA for advanced NSCLC is feasible, acceptable to patients and improves understanding of advanced NSCLC without increasing patient anxiety. Nature Publishing Group 2008-06-03 2008-05-27 /pmc/articles/PMC2410111/ /pubmed/18506180 http://dx.doi.org/10.1038/sj.bjc.6604395 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study Leighl, N B Shepherd, F A Zawisza, D Burkes, R L Feld, R Waldron, J Sun, A Payne, D Bezjak, A Tattersall, M H N Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer |
title | Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer |
title_full | Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer |
title_fullStr | Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer |
title_full_unstemmed | Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer |
title_short | Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer |
title_sort | enhancing treatment decision-making: pilot study of a treatment decision aid in stage iv non-small cell lung cancer |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410111/ https://www.ncbi.nlm.nih.gov/pubmed/18506180 http://dx.doi.org/10.1038/sj.bjc.6604395 |
work_keys_str_mv | AT leighlnb enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT shepherdfa enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT zawiszad enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT burkesrl enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT feldr enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT waldronj enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT suna enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT payned enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT bezjaka enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer AT tattersallmhn enhancingtreatmentdecisionmakingpilotstudyofatreatmentdecisionaidinstageivnonsmallcelllungcancer |